These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33264288)

  • 21. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
    Langley I; Lin HH; Egwaga S; Doulla B; Ku CC; Murray M; Cohen T; Squire SB
    Lancet Glob Health; 2014 Oct; 2(10):e581-91. PubMed ID: 25304634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
    Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
    BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.
    Cox SR; Kadam A; Atre S; Gupte AN; Sohn H; Gupte N; Sawant T; Mhadeshwar V; Thompson R; Kendall E; Hoffmann C; Suryavanshi N; Kerrigan D; Tripathy S; Kakrani A; Barthwal MS; Mave V; Golub JE;
    Trials; 2022 Aug; 23(1):635. PubMed ID: 35932062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.
    James R; Khim K; Boudarene L; Yoong J; Phalla C; Saint S; Koeut P; Mao TE; Coker R; Khan MS
    BMC Infect Dis; 2017 Aug; 17(1):580. PubMed ID: 28830372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa.
    Sekandi JN; Dobbin K; Oloya J; Okwera A; Whalen CC; Corso PS
    PLoS One; 2015; 10(2):e0117009. PubMed ID: 25658592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
    PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.
    Jha S; Ismail N; Clark D; Lewis JJ; Omar S; Dreyer A; Chihota V; Churchyard G; Dowdy DW
    PLoS One; 2016; 11(6):e0157554. PubMed ID: 27322162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru.
    Shah L; Rojas M; Mori O; Zamudio C; Kaufman JS; Otero L; Gotuzzo E; Seas C; Brewer TF
    Epidemiol Infect; 2017 Apr; 145(6):1107-1117. PubMed ID: 28162099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.
    van't Hoog AH; Cobelens F; Vassall A; van Kampen S; Dorman SE; Alland D; Ellner J
    PLoS One; 2013; 8(12):e82786. PubMed ID: 24367555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost analysis of rapid diagnostics for drug-resistant tuberculosis.
    Groessl EJ; Ganiats TG; Hillery N; Trollip A; Jackson RL; Catanzaro DG; Rodwell TC; Garfein RS; Rodrigues C; Crudu V; Victor TC; Catanzaro A
    BMC Infect Dis; 2018 Mar; 18(1):102. PubMed ID: 29499645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xpert(®) MTB/RIF for improved case detection of extra-pulmonary TB in a tertiary care setting in urban India.
    Nataraj G; Kanade S; Mehta P
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):890-4. PubMed ID: 27287640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model.
    Sohn H; Kasaie P; Kendall E; Gomez GB; Vassall A; Pai M; Dowdy D
    BMC Med; 2019 Aug; 17(1):155. PubMed ID: 31382959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Accuracy of Xpert
    Feng JN; Gao L; Sun YX; Yang JC; Deng SW; Sun F; Zhan SY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):320-326. PubMed ID: 33879905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.
    Solomon S; Balakrishnan P; Vignesh R; Waldrop G; Solomon SS; Murugavel KG; Kumarasamy N; Yepthomi T; Poongulali S; Swathirajan CR; Sreenivasan V; Chandrasekar C; Suriakumar J; Mahilmaran A; Manoharan G; Moore DA
    Indian J Med Microbiol; 2013; 31(2):130-7. PubMed ID: 23867668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incremental cost-effectiveness of the second Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis].
    Wang SQ; Sun Q; Jiang GL; Fu YY; Shang YY; Huang HR; Wang GR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):432-437. PubMed ID: 31189229
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.